India and management of COVID-19: A case study on published guidelines.
Coronavirus disease 2019
SARS-CoV-2
antiviral
Journal
Drug discoveries & therapeutics
ISSN: 1881-784X
Titre abrégé: Drug Discov Ther
Pays: Japan
ID NLM: 101493809
Informations de publication
Date de publication:
22 Sep 2021
22 Sep 2021
Historique:
pubmed:
27
8
2021
medline:
2
10
2021
entrez:
26
8
2021
Statut:
ppublish
Résumé
In the face of the ongoing pandemic, the primary care physicians in India are dealing not only with an increased number of patients but are also facing difficulties in the management of complex critically ill patients. To guide the management plans of primary care physicians, several guidelines have been published by the central and state health bodies. In such a situation, an updated and unifying state, national and international guidelines based on critical analysis and appraisal of evolving data is the need of the hour. In this review, we critically analysed the current existing guidelines that have been formulated within India in light of recent evidence.
Identifiants
pubmed: 34433755
doi: 10.5582/ddt.2021.01054
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM